Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

MVIS Stock: The Short Squeeze Powering 40% Gains Today

Today, it appears MVIS stock has earned its unofficial "meme stock" status as a short-squeeze candidate among social media-savvy investors.

GNUS Stock: 2 Big Catalysts Lifting Genius Brands Today

Today, GNUS stock is soaring higher as investors price in a couple of bullish catalysts into this digital media stock.

RVPH Stock: Why Reviva Pharmaceuticals Is Skyrocketing 90% on Monday

Today, investors in RVPH stock saw some pretty massive gains, as the company announced impressive results for its schizophrenia drug.

AMC Still Isn’t a Buy After CEO Says it Won’t Issue Shares This Year

Here's why I think AMC stock isn't worth more than $5 per share today, let alone anywhere close to the $10 per share level it's trading at.

CCIV Stock: The Speculation That Has Churchill Capital Racing Higher Today

Today, shareholders in CCIV stock are seeing some pretty impressive gains as rumors begin to build about a potential Apple partnership.